California State Teachers Retirement System decreased its position in Teladoc Inc (NYSE:TDOC) by 9.6% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 86,172 shares of the health services provider’s stock after selling 9,149 shares during the quarter. California State Teachers Retirement System’s holdings in Teladoc were worth $2,857,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the business. FMR LLC increased its position in Teladoc by 1.3% in the second quarter. FMR LLC now owns 8,209,737 shares of the health services provider’s stock worth $284,879,000 after buying an additional 106,500 shares in the last quarter. BlackRock Inc. increased its position in Teladoc by 42.9% in the second quarter. BlackRock Inc. now owns 3,844,402 shares of the health services provider’s stock worth $133,400,000 after buying an additional 1,154,852 shares in the last quarter. JPMorgan Chase & Co. increased its position in Teladoc by 24.4% in the third quarter. JPMorgan Chase & Co. now owns 3,313,729 shares of the health services provider’s stock worth $108,193,000 after buying an additional 650,129 shares in the last quarter. Vanguard Group Inc. increased its position in Teladoc by 11.5% in the second quarter. Vanguard Group Inc. now owns 3,041,725 shares of the health services provider’s stock worth $105,547,000 after buying an additional 314,646 shares in the last quarter. Finally, Eagle Asset Management Inc. increased its position in Teladoc by 2.2% in the third quarter. Eagle Asset Management Inc. now owns 2,106,830 shares of the health services provider’s stock worth $72,053,000 after buying an additional 45,794 shares in the last quarter.

A number of analysts have commented on the company. KeyCorp restated a “buy” rating and issued a $41.00 price target on shares of Teladoc in a research report on Wednesday. Cantor Fitzgerald restated a “hold” rating and issued a $31.00 price target on shares of Teladoc in a research report on Tuesday, September 26th. Cowen restated an “outperform” rating and issued a $39.00 price target on shares of Teladoc in a research report on Saturday, September 30th. CIBC restated an “outperform” rating and issued a $45.00 price target (up previously from $40.00) on shares of Teladoc in a research report on Tuesday, November 21st. Finally, Canaccord Genuity set a $42.00 price target on Teladoc and gave the stock a “buy” rating in a research report on Friday, November 17th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $39.31.

Shares of Teladoc Inc (NYSE:TDOC) opened at $33.20 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 5.08 and a current ratio of 5.08. Teladoc Inc has a 1 year low of $15.65 and a 1 year high of $38.40. The stock has a market capitalization of $2,010.00 and a PE ratio of -22.90.

Teladoc (NYSE:TDOC) last released its earnings results on Wednesday, November 1st. The health services provider reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.25). Teladoc had a negative return on equity of 29.70% and a negative net margin of 45.64%. The business had revenue of $68.70 million for the quarter, compared to analysts’ expectations of $67.53 million. During the same quarter in the prior year, the business posted ($0.33) EPS. The business’s revenue for the quarter was up 112.0% compared to the same quarter last year. analysts forecast that Teladoc Inc will post -1.56 EPS for the current fiscal year.

In other Teladoc news, CFO Mark Hirschhorn sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $32.99, for a total transaction of $989,700.00. Following the completion of the transaction, the chief financial officer now owns 5,203 shares in the company, valued at approximately $171,646.97. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jason N. Gorevic sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $32.99, for a total value of $3,299,000.00. Following the transaction, the chief executive officer now owns 718,261 shares of the company’s stock, valued at approximately $23,695,430.39. The disclosure for this sale can be found here. Insiders have sold 210,000 shares of company stock valued at $6,889,350 in the last quarter. 4.47% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “California State Teachers Retirement System Sells 9,149 Shares of Teladoc Inc (TDOC)” was posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/california-state-teachers-retirement-system-sells-9149-shares-of-teladoc-inc-tdoc/1803814.html.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.